Corrigendum to "Automated ELISA for potency measurements of therapeutic antibodies and antibody fragments" [J. Pharm. Biomed. Anal. 245 (2024) 116141]

J Pharm Biomed Anal. 2024 Dec 15:251:116439. doi: 10.1016/j.jpba.2024.116439. Epub 2024 Sep 3.

Authors

Guillaume Rey¹, Fabienne Schuetz¹, Daniela Schroeder¹, Christian Kaluschke¹, Markus W Wendeler¹, Irmgard Hofmann¹, Eva Dumbliauskas¹, Petr Obrdlik²

Affiliations

¹ Novartis Pharma AG, Technical Research and Development Biologics, Analytical Development Bioanalytics, Basel, Switzerland.
² Novartis Pharma AG, Technical Research and Development Biologics, Analytical Development Bioanalytics, Basel, Switzerland. Electronic address: petr.obrdlik@novartis.com.

PMID: 39232445
DOI: 10.1016/j.jpba.2024.116439

No abstract available

Publication types

Published Erratum